IP Library Granted Patent US 10,015,958
Granted Patent B2
US 10,015,958 · App. 14/651,366 · Granted Jul 10, 2018

Method of freezing making use of a mineral nucleator

Inventors: Benjamin John Murray (Leeds, GB); Thomas Francis Whale (Leeds, GB); James Atkinson (Leeds, GB); George John Morris (Cambridge, GB)
Assignees: University of Leeds; Asymptote Ltd
A01N1/0221A01N1/0268A01N1/0278A01N1/0284A23G9/325A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,015,958
App. No.
14/651,366
Granted
Jul 10, 2018
Kind
B2
Abstract

The present invention relates to a method for freezing a water-containing quantity of a biological entity or a formulation in a vessel using a mineral nucleator, to the use of the mineral as a nucleator and to a vessel with the mineral in or on the whole or part of a surface thereof.

Claims (27)

1. A method for freezing a water-containing quantity of a biological entity or a formulation comprising:

contacting the water-containing quantity of the biological entity or formulation with a framework silicate in a vessel to form a solution; and

freezing the solution at a supercooling temperature between 0° C. and 8° C. in the vessel, wherein the framework silicate promotes the non-spontaneous formation of ice at a supercooling temperature between 0° C. and 8° C.

2. A method as claimed in claim 1 wherein the framework silicate is selected from the group consisting of Feldspar, Silica, Nepheline, Petalite, Leucite, Sodalite, Cancrinite, Scapolite, Analcite and Zeolite.

3. A method as claimed in claim 1 wherein the framework silicate is a framework aluminosilicate.

4. A method as claimed in claim 1 wherein the framework silicate is a Feldspar or Feldsapthoid.

5. A method as claimed in claim 1 wherein the framework silicate is a Feldspar.

6. A method as claimed in claim 1 wherein the framework silicate is a Feldspar with a predominance of NaAlSi 3 O 8 and KAlSi 3 O 8 .

7. A method as claimed in claim 1 wherein the framework silicate is a Feldspar with a predominance of KAlSi 3 O 8 .

8. A method as claimed in claim 1 wherein the framework silicate is a Feldspar with a predominance of CaAl 2 Si 2 O 8 and NaAlSi 3 O 8 .

9. A method as claimed in claim 1 wherein the framework silicate is a Feldspar with a predominance of NaAlSi 3 O 8 .

10. A method as claimed in claim 1 wherein the water-containing quantity is a water-containing quantity of a medical formulation.

11. A method as claimed in claim 1 wherein the water-containing quantity is a water-containing quantity of a formulated foodstuff.

12. A method as claimed in claim 1 wherein the water-containing quantity is a water-containing quantity of a biological entity.

13. A method as claimed in claim 12 wherein the biological entity is a cell or aggregate of cells.

14. A method as claimed in claim 1 wherein the contacting the water-containing quantity with a framework silicate in a vessel comprises:

adding the water-containing quantity to the vessel; and

adding the framework silicate in a discrete form to the vessel.

15. A method as claimed in claim 1 wherein the framework silicate is in or on the whole or part of a surface of the vessel or part thereof such that active nucleation sites of the framework silicate are exposed effectively to the water-containing quantity and the contacting the water-containing quantity with a framework silicate in a vessel comprises adding the water-containing quantity to the vessel.

16. A method for freezing a water-containing quantity of a biological entity or a formulation comprising:

forming a solution comprising the water-containing quantity of the biological entity or formulation, and a framework silicate;

freezing the solution at a supercooling temperature between 0° C. and 8° C.; and

during the freezing, promoting the non-spontaneous formation of ice at the supercooling temperature between 0° C. and 8° C.

17. The method of claim 16 wherein the framework silicate comprises one or more of Feldspar, Silica, Nepheline, Petalite, Leucite, Sodalite, Cancrinite, Scapolite, Analcite and/or Zeolite.

18. The method of claim 16 wherein the forming the solution comprises:

adding the water-containing quantity to a vessel; and

adding the framework silicate in a discrete form to the vessel.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2024
From: ASYMPTOTE LIMITED
To: BIOSAFE SA
Reel/Frame 068268/0460 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2015
From: MURRAY, BENJAMIN JOHN; WHALE, THOMAS FRANCIS; ATKINSON, JAMES; MORRIS, GEORGE JOHN
To: UNIVERSITY OF LEEDS; ASYMPTOTE LTD
Reel/Frame 036453/0231 →
Priority Claims (1)
GB 1222241.0 · Dec 11, 2012 · national
Continuity (1)
Related Publication 20150327538A1 · Nov 19, 2015
Cited By (1)
US 12,382,953